Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2022

Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2022

Date: Tuesday, 1 March 2022 - Wednesday, 2 March 2022
Location: Rotterdam, The Netherlands


Conference Chair

Dominique PV de Kleijn

Dominique PV de Kleijn
Professor Experimental Vascular Surgery; Professor Netherlands Heart Institute, University Medical Center Utrecht

Keynote Speakers

Valérie Taly

Valérie Taly
CNRS Research Director, Group leader Translational Research and Microfluidics, University Paris Descartes

Dominique PV de Kleijn

Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands

Jan Lötvall

Jan Lötvall
Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles

Lorena Diéguez

Lorena Diéguez
Leader of the Medical Devices Research Group, INL- International Iberian Nanotechnology Laboratory

Sai Kiang Lim

Sai Kiang Lim
Research Director, Institute of Medical Biology, A*STAR

Steve Soper

Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas, Adjunct Professor, Ulsan National Institute of Science & Technology

Danilo Tagle

Danilo Tagle
Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS)

Overview

SelectBIO welcomes you to Circulating Biomarkers, Exosomes and Liquid Biopsy Europe 2022 to be held at the Hilton Rotterdam, The Netherlands.

This annual conference brings together academics and industry participants from around the world focused on research, biomarker analyses and therapeutics development leveraging the cargo from Exosomes and Extracellular Vesicles (EVs).

An important component of this conference is to focus upon the development of Liquid Biopsies utilizing circulating cell-free DNA (cfDNA), circulating tumour cells (CTCs) and other biomarkers found in biofluids.

Additionally, we focus at this conference on the Therapeutic and Drug Delivery Opportunities Enabled by Extracellular Vesicles (EVs). In this vein, key opinion leaders in this space will be presenting at this conference.

Presentations, Panel Discussions and Round-Table Workshops from key opinion leaders in the field form the basis of this conference and companies/vendors in the space participate to showcase their most up-to-date product and service offerings.

Rotterdam is an excellent host city for this conference with its excellent infrastructure, fast connections across Europe and easy access from around the world via Amsterdam-Schiphol.

**Proof of Covid-19 Vaccination Required in Order to Participate On-Site at this Event.  Participants Not Vaccinated for Covid-19 Can Participate Virtually at this Event.**Conference Held in Compliance with Dutch Government Guidelines**

Agenda Topics

  • Circulating Cell-Free DNA (cfDNA) for Liquid Biopsy Development
    • Companies Showcase
    • Technologies for Mutation Detection and Analysis
  • Circulating Tumour Cells (CTCs) for Liquid Biopsy Development
    • Companies Showcase
    • Emerging Technology Trends
  • Exosomes and Extracellular Vesicles (EV) Biomarker Potential
    • Proteins, DNA and Lipids
    • RNA Cargo
  • Exosomes and Extracellular Vesicles (EV) Research Trends
  • Exosomes and Extracellular Vesicles (EV) Studies in Various Diseases
    • Cancer
    • Cardiovascular Disease
    • CNS Disease
  • Isolation and Characterization of Exosomes and EV Classes
  • Modification and Engineering of Exosomes and EVs
  • Therapeutics Opportunities: Pharmaceutical/Drug Targeting of Disease using Exosomes/EVs
    • Biologics Delivered Using EVs
    • Drug Delivery Using EVs
    • Technologies for Engineering EVs for Therapeutics, Drug Delivery Vehicles

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Dimitri Aubert, Managing Director, NanoFCM Co., Ltd
Jan Brants, Regional Sales Director - France Benelux, NanoView Biosciences
Jean-Luc Fraikin, CEO, Spectradyne
Bernd Giebel, Group Leader, Institute for Transfusion Medicine, University Hospital Duisburg-Essen
Andrea Huxhold, Senior Scientific Marketing Manager, QIAGEN/PreAnalytiX
Stephanie Jordaens, Biomedical Scientist, University of Antwerp and Novosanis
Sven Rudolf Kreutel, Chief Executive Officer, Particle Metrix GmbH and CEO, Particle Metrix Inc., USA
Lauren Leiman, Executive Director, Blood Profiling Atlas in Cancer (BloodPAC)
Jean Lewis, Associate Director, Research, Biological Dynamics
Stephane Mazlan, Scientific and Business Coordinator, Izon Science
Andreas Möller, Associate Professor, Group Leader and Head, Tumour Microenvironment Laboratory, QIMR Berghofer Medical Research Institute
D. Michiel Pegtel, Associate Professor, Amsterdam University Medical Center
Michael Pfaffl, Professor, Technical University of Munich
Matthew Rodrigues, Instrument Field Application Scientist, Luminex Corporation
Roel Schaapveld, Chief Executive Officer, InteRNA Technologies BV
Magdalena Schimke, Business Development and Single Cell Scientist, STRATEC Consumables GmbH
Edwin van der Pol, Assistant Professor, Amsterdam University Medical Center
Erik Vollebregt, Partner, Axon Lawyers
Ronald Vos, Business Development Manager, SensID
Bas WM van Balkom, Assistant Professor, University Medical Center Utrecht


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2022-03-01 00:00:002022-03-02 00:00:00Europe/LondonCirculating Biomarkers, Exosomes and Liquid Biopsy Europe 2022Circulating Biomarkers, Exosomes and Liquid Biopsy Europe 2022 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com